亚洲 · 股市与财经 · CNBC-TV18
Rubicon Research gets one US FDA Form 483 observation after Satara plant inspection
Rubicon Research's Satara manufacturing facility received one procedural observation in Form 483 following an unannounced US FDA inspection conducted from October 5 to 9.
在 CNBC-TV18 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.cnbctv18.com)




